Difference between revisions of "PGM-pathway control state"
Line 20: | Line 20: | ||
:::[[SUIT-008 O2 pce D025]] | :::[[SUIT-008 O2 pce D025]] | ||
:::[[SUIT-014]] | :::[[SUIT-014]] | ||
:::[[SUIT- | :::[[SUIT-012]] | ||
== PGM(E) == | == PGM(E) == | ||
Line 28: | Line 28: | ||
:::[[SUIT-001 O2 pce D003]] | :::[[SUIT-001 O2 pce D003]] | ||
:::[[SUIT-001 O2 pce D004]] | :::[[SUIT-001 O2 pce D004]] | ||
:::[[SUIT- | :::[[SUIT-012]] | ||
Β | |||
== Discussion == | == Discussion == |
Revision as of 13:43, 22 January 2019
Description
PGM: Pyruvate & Glutamate & Malate.
MitoPathway control state: N
SUIT protocol: SUIT-001
Pyruvate (P) is oxidatively decarboxylated to acetyl-CoA and CO2, yielding NADH catalyzed by pyruvate dehydrogenase. Malate (M) is oxidized to oxaloacetate by mt-malate dehydrogenase located in the mitochondrial matrix. Condensation of oxaloacate with acetyl-CoA yields citrate (citrate synthase). Glutamate&malate is a substrate combination supporting an N-linked pathway control state, when glutamate is transported into the mt-matrix via the glutamate-aspartate carrier and reacts with oxaloacetate in the transaminase reaction to form aspartate and oxoglutarate. Glutamate as the sole substrate is transported by the electroneutral glutamate-/OH- exchanger, and is oxidized in the mitochondrial matrix by glutamate dehydrogenase to Ξ±-ketoglutarate ( 2-oxoglutarate), representing the glutamate anaplerotic pathway control state. 2-oxoglutarate (Ξ±-ketoglutarate) is formed from isocitrate (isocitrate dehydrogenase, from oxaloacetate and glutamate by the transaminase, and from glutamate by the glutamate dehydrogenase.
Abbreviation: PGM
Reference: Gnaiger 2014 MitoPathways - Chapter 5.3
MitoPedia concepts:
SUIT state
PGM(L)
PGM(P)
PGM(E)